|
Container
|
Title
|
|
Correspondence
|
|
|
Box
3
|
International Pharmaceutical Federation, 1975-1979
|
|
|
Box
3
|
Beckett commission report and correspondence, 1975
|
|
|
Box
3
|
General correspondence, 1976-1977
|
|
|
Box
3
|
Hague meeting, February 27, 1977
|
|
|
Box
3
|
Brighton, 1979
|
|
|
Box
3
|
Kok, Winters, Faure correspondence, 1974-1978
|
|
|
Box
3
|
Madame Oslet, 1976-1979
|
|
|
Box
3
|
Monsieur André Bedat, 1975-1974
|
|
|
Box
3
|
International Pharmaceutical Federation, 1975-1979
|
|
|
Box
3
|
Procedures and correspondence, 1975
|
|
|
Box
3
|
Cannes, 1978
|
|
|
Box
3
|
Mutation sheets, 1975
|
|
|
Box
3
|
Reports, 1975
|
|
|
Box
3
|
Statements, 1975
|
|
|
Box
3
|
B
|
|
|
Box
3
|
Alex Berman, 1975-1976
|
|
|
Box
3
|
Paul Blanc, 1972-1977
|
|
|
Box
3
|
Czechoslovakia, 1977-1978
|
|
|
Box
3
|
D
|
|
|
Box
3
|
Denmark
|
|
|
Box
3
|
Evans, including curriculum vitae for R.C. Wilson
|
|
|
Box
3
|
Excerpta Medica, the Netherlands
|
|
|
Box
3
|
F
|
|
|
Box
3
|
The two Martindales speech by W.K. Fitch
|
|
|
Box
3
|
Food and Drug Administration
|
|
|
Box
3
|
Finland
|
|
|
Box
3
|
France, Arnal, Cheymal, Lesar, Reusse, Valette
|
|
|
Box
3
|
G
|
|
|
Box
3
|
Ulisse Gallo
|
|
|
Box
3
|
Leo Godley
|
|
|
Box
3
|
Goyan
|
|
|
Box
3
|
Great Britain
|
|
|
Box
3
|
Greece
|
|
|
Box
3
|
Grider family medical prescription records
|
|
|
Box
3
|
H
|
|
|
Box
3
|
Heller, United States Pharmacopeia
|
|
|
Box
3
|
Dennis K. Helling, University of Iowa
|
|
|
Box
3
|
Takeru Higuchi, curriculum vitae
|
|
|
Box
3
|
Hirschman
|
|
|
Box
3
|
Holland, Sorgdreger
|
|
|
Box
3
|
Holloway, D., drug problems and the geriatric patient
|
|
|
Box
3
|
Hospital formulary, George Archambault, Editor
|
|
|
Box
3
|
Howard bulletin
|
|
|
Box
3
|
Department of health, education and welfare peer review, Knoben
|
|
|
Box
3
|
I
|
|
|
Box
3
|
Index Medicus
|
|
|
Box
3
|
India
|
|
|
Box
3
|
International Pharmaceutical Students' Federation (IPSF)
|
|
|
Box
3
|
IPSF, Finland
|
|
|
Box
3
|
Ireland
|
|
|
Box
3
|
Israel
|
|
|
Box
3
|
Italy
|
|
|
Box
3
|
J
|
|
|
Box
3
|
Japan, Ishidate
|
|
|
Box
3
|
K
|
|
|
Box
3
|
Knapp, David A. and Francis B, Palumbo article
|
|
|
Box
3
|
Knoben
|
|
|
Box
3
|
Korea
|
|
|
Box
3
|
Kramer, Warren A.
|
|
|
Box
3
|
L
|
|
|
Box
3
|
Lilly and Company, Eli
|
|
|
Box
3
|
Lithium, clinical effectiveness comparisons with other drugs article
|
|
|
Box
3
|
M
|
|
|
Box
3
|
Malta
|
|
|
Box
3
|
Margaret M. McCarron
|
|
|
Box
3
|
McCart, Gary
|
|
|
Box
3
|
McLeod, Don C.
|
|
|
Box
3
|
Miller, William A. Developing and maintaining clinical pharmacy services article
|
|
|
Box
3
|
Millis report, pharmacists for the future
|
|
|
Box
3
|
Paul Pierpaoli
|
|
|
Box
3
|
Smecka, Dr. Vladimir, Czechoslovakia
|
|
|
Box
3
|
Smith, Dorothy, Toronto
|
|
|
Box
3
|
Smith, William; Long Beach, California
|
|
|
Box
3
|
Sonnedecker
|
|
|
Box
3
|
Thailand, Koairiksh
|
|
|
Box
3
|
University of Michigan
|
|
|
Box
3
|
Valette's paper
|
|
|
Box
3
|
Varano, Carmine
|
|
|
Box
3
|
Yugoslavia, Bkagojevic, Depeder
|
|
|
Box
3
|
Wertheimer
|
|
|
Box
3
|
White, Eugene
|
|
|
Box
3
|
Whittet, Dr. T. Douglas
|
|
|
Box
4
|
Spain
|
|
|
Box
4
|
South Africa
|
|
|
Box
4
|
Saint Johns University, Jane Durgin, “Manual for Pharmacy Technicians”
|
|
|
Box
4
|
Sweden
|
|
|
Box
4
|
Switzerland
|
|
|
Box
4
|
Provost, George
|
|
|
Box
4
|
Nigeria, Egboh, Kucera, Oke
|
|
|
Box
4
|
International Pharmaceutical Federation (FIP)
|
|
|
Box
4
|
New member letters to Holland
|
|
|
Box
4
|
General correspondence with M. Felix-Faure, 1978
|
|
|
Box
4
|
Bank deposits, 1977
|
|
|
Box
4
|
Mutation sheets, 1977
|
|
|
Box
4
|
Reports, 1977
|
|
|
Box
4
|
General correspondence with members, 1977
|
|
|
Box
4
|
General correspondence with M. Felix-Faure, 1977
|
|
|
Box
4
|
Reports, 1976
|
|
|
Box
4
|
Bank deposits, 1976
|
|
|
Box
4
|
General correspondence with Felix-Faure, 1976
|
|
|
Box
4
|
Reception letters, 1967
|
|
|
Box
4
|
General correspondence with members, 1976
|
|
|
Box
4
|
Reports, 1974
|
|
|
Box
4
|
Pharmaceutical journal clippings
|
|
|
Box
4
|
Publications, 1970-1978
|
|
|
Box
4
|
Bibliographic notes, circa 1970
|
|
|
Box
4
|
Pending, 1975
|
|
|
Box
4
|
Correspondence with M. Felix-Faure
|
|
|
Box
4
|
Drug Intelligence and Clinical Pharmacy (DICP)
|
|
|
Box
4
|
“DICP,” April 1979
|
|
|
Box
4
|
April masters
|
|
|
Box
4
|
“The Uncertain Future of Drug Development,” Louis Lasagna, Rho Chi lecture award
|
|
|
Box
4
|
Adverse reactions of antipsychotic drugs, Inoue
|
|
|
Box
4
|
Some perspectives on US pharmacy, Polack
|
|
|
Box
4
|
Prazosin hydrochloride: an unloading agent
|
|
|
Box
4
|
Allopurinol hypersensitivity, Burkle
|
|
|
Box
4
|
Non-government alternatives to unit of use packaging, Heller
|
|
|
Box
4
|
“DICP,” May 1979
|
|
|
Box
4
|
May masters
|
|
|
Box
4
|
“DICP,” March 1979
|
|
|
Box
4
|
Drug evaluation data, cefamandole (mandol)
|
|
|
Box
4
|
March master galleys
|
|
|
Box
4
|
“Drug Compliance a Study of Patient Behavior Based on Medical Records,” Taubman
|
|
|
Box
4
|
The effects of price information on physician prescribing patterns: a literature review
|
|
|
Box
4
|
Successful treatment of apparent methicillin resistant staphylococcus aureus endocarditis with gentamicin and cephalothin
|
|
|
Box
4
|
March rounds, 1978
|
|
|
Box
4
|
Treatment of disseminated herpes zoster infections
|
|
|
Box
4
|
Clinical pharmacy service contributions on a part time basis, Self and Eoff
|
|
|
Box
4
|
Quinidine-Digoxin interaction: a discussion of a case report and review of the literature, Small
|
|
|
Box
4
|
The utilization of a clinical pharmacist: a way of decreasing medications in a community hospital
|
|
|
Box
4
|
Biopharmaceutics and clinical pharmacy
|
|
|
Box
4
|
Clinical pharmacy talk to Georgia Society of Hospital Pharmacists
|
|
|
Box
4
|
The future directory of drug information services, American Society of Health System-Pharmacists, 1972
|
|
|
Box
4
|
Speeches and articles by Donald E. Francke
|
|
|
Box
4
|
Control of investigational drugs in hospitals, France
|
|
|
Box
4
|
Drug bulletins, University Hospital, Ann Arbor, Michigan, 1957
|
|
|
Box
4
|
“Our Most Valuable Heritage” speech, Austin Smith, 1962
|
|
|
Box
5
|
“DICP,” September 1978
|
|
|
Box
5
|
DICP layout, September 1978
|
|
|
Box
5
|
September master
|
|
|
Box
5
|
Pka values of medicinal compounds in pharmacy practice
|
|
|
Box
5
|
Medication taking behavior of the elderly: a pilot study
|
|
|
Box
5
|
Oral contraceptive associated liver tumors: an update
|
|
|
Box
5
|
Therapeutic management of cirrhotic ascites, Fong, Jue and Nagata
|
|
|
Box
5
|
Eosinophilia and intravenous methylphenidate (Ritalin) abuse, Gill et al.
|
|
|
Box
5
|
Drug Information Analysis Service [DIAS] rounds for September
|
|
|
Box
5
|
Master galleys, February 1979
|
|
|
Box
5
|
Parental 5-Fluorocytosine for candidiasis
|
|
|
Box
5
|
Drug information, the problem and some solutions
|
|
|
Box
5
|
Intravenous ethchlorvynol-induced pulmonary edema
|
|
|
Box
5
|
Decision tables for planning drug therapy, Miller
|
|
|
Box
5
|
December index
|
|
|
Box
5
|
Prescriptions ordered by podiatrists for ambulatory patients: an exploratory study
|
|
|
Box
5
|
December DIAS rounds
|
|
|
Box
5
|
“Monitoring Drug Therapy in Skilled Nursing Facility Patients”
|
|
|
Box
5
|
“DICP,” December 1978
|
|
|
Box
5
|
“The Pharmacist as a Consultant Five Years Later,” Vanderveen
|
|
|
Box
5
|
“A Quantitative Assessment of the Readability of PPIs,” S. Ligouri
|
|
|
Box
5
|
Editorial advisory board new appointments, 1977
|
|
|
Box
5
|
Editorial advisory board DICP
|
|
|
Box
5
|
Editorial board, 1978
|
|
|
Box
5
|
Drug evaluation data
|
|
|
Box
5
|
Editorials
|
|
|
Box
5
|
Future issues
|
|
|
Box
5
|
Hamilton Press
|
|
|
Box
5
|
Health care sociology
|
|
|
Box
5
|
Richard Huff, DICP artist
|
|
|
Box
5
|
Letters to the editor and replies, 1975
|
|
|
Box
5
|
General correspondence
|
|
|
Box
5
|
Microfilm
|
|
|
Box
5
|
News releases
|
|
|
Box
5
|
Responses to news releases
|
|
|
Box
5
|
Questionnaire master for cards
|
|
|
Box
5
|
Correspondence questionnaire
|
|
